Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Are there specific clinical characteristics associated with physician's treatment choices in COPD?

Roche N, Antoniadis A, Hess D, Li PZ, Kelkel E, Leroy S, Pison C, Burgel PR, Aguilaniu B; COLIBRI COPD Research Group.

Respir Res. 2019 Aug 20;20(1):189. doi: 10.1186/s12931-019-1156-1.

2.

Trends over time in COPD treatment choices by respiratory physicians: An analysis from the COLIBRI-COPD French cohort.

Roche N, Aguilaniu B, Zhi Li P, Hess D; COLIBRI collaborators.

Respir Med. 2019 Sep;156:8-14. doi: 10.1016/j.rmed.2019.07.023. Epub 2019 Jul 26.

PMID:
31374262
3.

Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients.

Lévesque J, Antoniadis A, Li PZ, Herengt F, Brosson C, Grosbois JM, Bernady A, Bender A, Favre M, Guerder A, Surpas P, Similowski T, Aguilaniu B.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 22;14:261-269. doi: 10.2147/COPD.S187567. eCollection 2019.

4.

COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners.

Meeraus W, Wood R, Jakubanis R, Holbrook T, Bizouard G, Despres J, Silva CCD, Nachbaur G, Landis SH, Punekar Y, Aguilaniu B, Ismaila AS.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 18;14:51-63. doi: 10.2147/COPD.S181224. eCollection 2019.

5.

The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear.

Morélot-Panzini C, Perez T, Sedkaoui K, de Bock E, Aguilaniu B, Devillier P, Pignier C, Arnould B, Bruneteau G, Similowski T.

Respir Med. 2018 Dec;145:1-7. doi: 10.1016/j.rmed.2018.10.010. Epub 2018 Oct 17.

PMID:
30509697
6.

Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic.

Morélot-Panzini C, Adler D, Aguilaniu B, Allard E, Bautin N, Beaumont M, Blanc FX, Chenivesse C, Dangers L, Delclaux C, Demoule A, Devillier P, Didier A, Georges M, Housset B, Janssens JP, Laveneziana P, Laviolette L, Muir JF, Ninot G, Perez T, Peiffer C, Schmidt M, Similowski T, Straus C, Taillé C, Van Den Broecke S, Roche N; dyspnoea working group of the Société de Pneumologie de Langue Française.

Eur Respir J. 2017 Sep 27;50(3). pii: 1701159. doi: 10.1183/13993003.01159-2017. Print 2017 Sep. No abstract available.

7.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 21. pii: S0761-8425(17)30209-7. doi: 10.1016/j.rmr.2017.07.018. [Epub ahead of print] French. No abstract available.

8.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):900-968. doi: 10.1016/j.rmr.2017.07.017. Epub 2017 Sep 20. No abstract available.

PMID:
28939155
9.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):852-899. doi: 10.1016/j.rmr.2017.07.019. Epub 2017 Sep 20. No abstract available.

PMID:
28939154
10.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 18. pii: S0761-8425(17)30211-5. doi: 10.1016/j.rmr.2017.07.020. [Epub ahead of print] French. No abstract available.

PMID:
28935497
11.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 19. pii: S0761-8425(17)30212-7. doi: 10.1016/j.rmr.2017.07.021. [Epub ahead of print] French. No abstract available.

PMID:
28935496
12.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):834-851. doi: 10.1016/j.rmr.2017.07.022. Epub 2017 Sep 19. No abstract available.

PMID:
28935495
13.

Physiologic Determinants of Exercise Capacity in Pulmonary Langerhans Cell Histiocytosis: A Multidimensional Analysis.

Rolland-Debord C, Fry S, Giovannelli J, Langlois C, Bricout N, Aguilaniu B, Bellocq A, Le Rouzic O, Dominique S, Delobbe A, François G, Tazi A, Wallaert B, Chenivesse C.

PLoS One. 2017 Jan 10;12(1):e0170035. doi: 10.1371/journal.pone.0170035. eCollection 2017.

14.

Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.

Morélot-Panzini C, Gilet H, Aguilaniu B, Devillier P, Didier A, Perez T, Pignier C, Arnould B, Similowski T.

Eur Respir J. 2016 Jun;47(6):1668-79. doi: 10.1183/13993003.01998-2015. Epub 2016 Apr 13.

15.

[COLIBRI: Improving clinical practice and producing relevant scientific data].

Kelkel E, Herengt F, Ben Saidane H, Veale D, Jeanjean C, Pison C, Pernot J, Pépin JL, Guillaud-Segard B, Gonzalez-Bermejo J, Aguilaniu B.

Rev Mal Respir. 2016 Jan;33(1):5-16. doi: 10.1016/j.rmr.2015.02.090. Epub 2015 Jul 7. French.

PMID:
26163395
16.

[Cardiopulmonary exercise testing and dyspnea in patients with chronic respiratory diseases].

De Jesus AM, Chabrol J, Aguilaniu B, Wallaert B.

Rev Mal Respir. 2014 Oct;31(8):754-64. doi: 10.1016/j.rmr.2014.04.101. Epub 2014 Jul 9. Review. French.

PMID:
25391510
17.

A simple semipaced 3-minute chair rise test for routine exercise tolerance testing in COPD.

Aguilaniu B, Roth H, Gonzalez-Bermejo J, Jondot M, Maitre J, Denis F, Similowski T.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 23;9:1009-19. doi: 10.2147/COPD.S59855. eCollection 2014.

18.

Breathing patterns during eccentric exercise.

Lechauve JB, Perrault H, Aguilaniu B, Isner-Horobeti ME, Martin V, Coudeyre E, Richard R.

Respir Physiol Neurobiol. 2014 Oct 1;202:53-8. doi: 10.1016/j.resp.2014.07.007. Epub 2014 Jul 30.

PMID:
25083913
19.

[Physiological significance and interpretation of plasma lactate concentration and pH in clinical exercise testing].

Péronnet F, Aguilaniu B.

Rev Mal Respir. 2014 Jun;31(6):525-51. doi: 10.1016/j.rmr.2014.04.002. Epub 2014 May 17. Review. French.

PMID:
25012038
20.

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.

Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Aguilaniu B, Bouquillon B, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Kouzan S, Lebargy F, Marchand-Adam S, Philippe B, Prévot G, Stach B, Thivolet-Béjui F, Cordier JF; French National Reference Centre; Network of Competence Centres for Rare Lung Diseases.

Eur Respir Rev. 2014 Jun;23(132):193-214. doi: 10.1183/09059180.00001814. Review.

21.

The difficulties of measuring and improving physical activity in COPD.

Aguilaniu B, Roche N.

NPJ Prim Care Respir Med. 2014 May 20;24:14014. doi: 10.1038/npjpcrm.2014.14. No abstract available.

22.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Société de Pneumologie de Langue Française].

Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, Delaval P, Israel-Biet D, Kessler R, Reynaud-Gaubert M, Cordier JF, Aguilaniu B, Bouquillon B, Carré P, Danel C, Faivre JB, Ferreti G, Just N, Kouzan S, Lebargy F, Marchand Adam S, Philippe B, Prévot G, Stach B, Thivolet-Béjui F; French National Reference and Competence Centers for Rare Diseases; Societe de Pneumologies de Langue Francaise.

Rev Mal Respir. 2013 Dec;30(10):879-902. doi: 10.1016/j.rmr.2013.09.007. Epub 2013 Oct 25. French. No abstract available. Erratum in: Rev Mal Respir. 2014 Feb;31(2):194-5.

23.

[Cardiopulmonary exercise testing and unexpected dyspnea].

Aguilaniu B, Tercé G, Wallaert B.

Rev Mal Respir. 2013 Dec;30(10):856-67. doi: 10.1016/j.rmr.2013.09.012. Epub 2013 Nov 6. Review. French.

PMID:
24314709
24.

[Illustrated interpretation of cardio-pulmonary exercise testing].

Aguilaniu B, Wallaert B.

Rev Mal Respir. 2013 Dec;30(10):812-3. doi: 10.1016/j.rmr.2013.09.011. Epub 2013 Nov 19. French. No abstract available.

25.

[From interpretation of cardiopulmonary exercise testing to medical decision].

Aguilaniu B, Wallaert B.

Rev Mal Respir. 2013 Jun;30(6):498-515. doi: 10.1016/j.rmr.2013.05.002. Epub 2013 Jun 28. Review. French.

PMID:
23835322
26.

[Widening of the alveolar-arterial oxygen gradient during incremental exercise].

Aguilaniu B, Péronnet F.

Rev Mal Respir. 2012 Dec;29(10):1224-37. doi: 10.1016/j.rmr.2012.05.018. Epub 2012 Nov 13. Review. French.

PMID:
23228680
27.

[Pulmonary and alveolar ventilation, gas exchanges and arterial blood gases during ramp exercise].

Péronnet F, Aguilaniu B.

Rev Mal Respir. 2012 Oct;29(8):1017-34. doi: 10.1016/j.rmr.2012.09.005. Epub 2012 Oct 9. French.

PMID:
23101643
28.

[Prevention of COPD exacerbation: a fundamental challenge].

Roche N, Aguilaniu B, Burgel PR, Durand-Zaleski I, Dusser D, Escamilla R, Perez T, Raherison C, Similowski T; groupe d’expert « Exacerbations de BPCO ».

Rev Mal Respir. 2012 Jun;29(6):756-74. doi: 10.1016/j.rmr.2012.04.006. Epub 2012 Jun 6. Review. French.

PMID:
22742463
29.

[From exercise physiology to medical decision].

Aguilaniu B, Wallaert B.

Rev Mal Respir. 2011 Dec;28(10):1201-2. doi: 10.1016/j.rmr.2011.10.003. Epub 2011 Nov 8. French. No abstract available.

PMID:
22152929
30.

Effects of training at mild exercise intensities on quadriceps muscle energy metabolism in patients with chronic obstructive pulmonary disease.

Guzun R, Aguilaniu B, Wuyam B, Mezin P, Koechlin-Ramonatxo C, Auffray C, Saks V, Pison C.

Acta Physiol (Oxf). 2012 Jun;205(2):236-46. doi: 10.1111/j.1748-1716.2011.02388.x. Epub 2012 Jan 9.

PMID:
22118364
31.

Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity.

Wallaert B, Talleu C, Wemeau-Stervinou L, Duhamel A, Robin S, Aguilaniu B.

Respiration. 2011;82(6):501-8. doi: 10.1159/000330050. Epub 2011 Sep 20.

32.

Beyond corticosteroids: future prospects in the management of inflammation in COPD.

Roche N, Marthan R, Berger P, Chambellan A, Chanez P, Aguilaniu B, Brillet PY, Burgel PR, Chaouat A, Devillier P, Escamilla R, Louis R, Mal H, Muir JF, Pérez T, Similowski T, Wallaert B, Aubier M.

Eur Respir Rev. 2011 Sep 1;20(121):175-82. doi: 10.1183/09059180.00004211. Review.

33.

Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice.

Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T.

Int J Chron Obstruct Pulmon Dis. 2011;6:387-98. doi: 10.2147/COPD.S20007. Epub 2011 Jul 5.

34.

[COPD and inflammation: Statement from a French expert group. How to treat inflammation?].

Roche N, Devillier P, Aguilaniu B, Escamilla R, Wallaert B, Burgel PR, Berger P, Brillet PY, Chambellan A, Chanez P, Chaouat A, Louis R, Mal H, Marthan R, Muir JF, Pérez T, Similowski T, Aubier M.

Rev Mal Respir. 2011 Apr;28(4):427-42. doi: 10.1016/j.rmr.2010.08.017. Epub 2011 Mar 22. Review. French.

PMID:
21549899
35.

[Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis].

Wallaert B, Guetta A, Wemeau-Stervinou L, Tercé G, Valette M, Nevière R, Aguilaniu B.

Rev Mal Respir. 2011 Mar;28(3):290-6. doi: 10.1016/j.rmr.2010.08.016. Epub 2011 Feb 22. French.

PMID:
21482330
36.

[COPD and inflammation: statement from a French expert group. Phenotypes related to inflammation].

Perez T, Mal H, Aguilaniu B, Brillet PY, Chaouat A, Louis R, Muir JF, Similowski T, Berger P, Burgel PR, Chambellan A, Chanez P, Devillier P, Escamilla R, Marthan R, Wallaert B, Aubier M, Roche N.

Rev Mal Respir. 2011 Feb;28(2):192-215. doi: 10.1016/j.rmr.2010.08.011. Epub 2011 Feb 12. Review. French.

PMID:
21402234
37.

Detection of disturbances in pulmonary gas exchanges during exercise from arterialized earlobe PO2.

Aguilaniu B, Maitre J, Diab S, Perrault H, Péronnet F.

Respir Physiol Neurobiol. 2011 Jun 30;177(1):30-5. doi: 10.1016/j.resp.2011.03.005. Epub 2011 Mar 17.

PMID:
21397053
38.

Determinants of dyspnea and alveolar hypoventilation during exercise in cystic fibrosis: impact of inspiratory muscle endurance.

Leroy S, Perez T, Neviere R, Aguilaniu B, Wallaert B.

J Cyst Fibros. 2011 May;10(3):159-65. doi: 10.1016/j.jcf.2010.12.006. Epub 2011 Feb 22.

39.

[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms].

Aubier M, Marthan R, Berger P, Chambellan A, Chanez P, Aguilaniu B, Brillet PY, Burgel PR, Chaouat A, Devillier P, Escamilla R, Louis R, Mal H, Muir JF, Pérez T, Similowski T, Wallaert B, Roche N.

Rev Mal Respir. 2010 Dec;27(10):1254-66. doi: 10.1016/j.rmr.2010.10.004. Epub 2010 Nov 11. Review. French.

PMID:
21163401
40.

[Cardiopulmonary exercise testing in patients with pectus excavatum].

Cavestri B, Wurtz A, Bart F, Nevière R, Aguilaniu B, Wallaert B.

Rev Mal Respir. 2010 Sep;27(7):717-23. doi: 10.1016/j.rmr.2010.06.015. Epub 2010 Aug 1. French.

PMID:
20863972
41.

Impact of bronchodilator therapy on exercise tolerance in COPD.

Aguilaniu B.

Int J Chron Obstruct Pulmon Dis. 2010 Apr 7;5:57-71. Review.

42.

[Prognostic value of clinical exercise testing in adult patients with cystic fibrosis].

Nguyen S, Leroy S, Cracowski C, Perez T, Valette M, Neviere R, Aguilaniu B, Wallaert B.

Rev Mal Respir. 2010 Mar;27(3):219-25. doi: 10.1016/j.rmr.2010.01.009. Epub 2010 Mar 4. French.

PMID:
20359613
43.

[Dyspnea and handicap in chronic obstructive pulmonary disease: interaction of their mechanisms].

Aguilaniu B, Plaindoux A, Brosson C, Jeanmart M, Maitre J, Diab S.

Presse Med. 2009 Mar;38(3):413-20. doi: 10.1016/j.lpm.2008.12.002. Epub 2009 Jan 17. French.

PMID:
19152776
44.

A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.

Caillaud D, Le Merre C, Martinat Y, Aguilaniu B, Pavia D.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):559-65.

45.

European reference equations for CO and NO lung transfer.

Aguilaniu B, Maitre J, Glénet S, Gegout-Petit A, Guénard H.

Eur Respir J. 2008 May;31(5):1091-7. doi: 10.1183/09031936.00063207. Epub 2008 Jan 23.

46.

Cycling efficiency is not compromised for moderate exercise in moderately severe COPD.

Perrault H, Gravel G, Ofir D, Rittmaster D, Aguilaniu B, Bourbeau J.

Med Sci Sports Exerc. 2007 Jun;39(6):918-25.

PMID:
17545880
47.

[Cardiopulmonary exercise testing].

Aguilaniu B, Richard R, Costes F, Bart F, Martinat Y, Stach B, Denjean A; Scientific Council of the French Lung Society.

Rev Mal Respir. 2007 Mar;24(3 Pt 2):2S111-60. Review. French. No abstract available.

PMID:
17389842
48.

Air trapping in mild and moderate asthma: effect of inhaled corticosteroids.

Tunon-de-Lara JM, Laurent F, Giraud V, Perez T, Aguilaniu B, Meziane H, Basset-Merle A, Chanez P.

J Allergy Clin Immunol. 2007 Mar;119(3):583-90. Epub 2007 Jan 3.

PMID:
17204317
49.

Stage-related changes in functional capacity in Hodgkin's disease: assessment by cardiopulmonary exercise testing before initiation of treatment.

Page E, Assouline D, Durand C, Brun O, Coeffic D, Fric D, Garnier C, Leyronnas C, Alcalay V, Aguilaniu B.

Ann Hematol. 2006 Dec;85(12):857-61. Epub 2006 Sep 13.

PMID:
16969675
50.

Bicarbonate infusion and pH clamp moderately reduce hyperventilation during ramp exercise in humans.

Péronnet F, Meyer T, Aguilaniu B, Juneau CE, Faude O, Kindermann W.

J Appl Physiol (1985). 2007 Jan;102(1):426-8. Epub 2006 Sep 7.

Supplemental Content

Loading ...
Support Center